Business Intelligence

Eli Lilly CEO Says Strategy And Reputation Among Concerns Facing Healthcare Experts

Download Now Free registration required

Executive Summary

Whether they grapple with technology, consumer expectations or new global markets, participants in the Kellogg School's Nov. 1 Business of Healthcare Conference agreed that, for now, the only constant in their industry is change. "It's frankly absurd to lay the many dysfunctions of the U.S. healthcare system on the doorstep of pharmaceutical companies' but unless one can restore trust and deliver unambiguous benefits to as many people as possible," Lechleiter predicted, the industry's image and stock values will continue to suffer.

  • Format: HTML
  • Size: 0 KB